RLMD (STOCKS)
Relmada Therapeutics, Inc. Common Stock
$6.440400
-0.209600 (-3.15%)
Prev close: $6.650000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Sergio Traversa
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $667.10M
- Employees
- 17
- P/E (TTM)
- -5.73
- P/B (TTM)
- 3.19
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.